Rachel Soyoun Kim, MD, MHSc, FRCSC - From Evidence to Practice: Combining Immunotherapy With Chemoradiotherapy Regimens in Locally Advanced Cervical Cancer

Visit https://www.peervoice.com/WFR860 to view the entire programme with slides. After completing “Rachel Soyoun Kim, MD, MHSc, FRCSC - From Evidence to Practice: Combining Immunotherapy With Chemoradiotherapy Regimens in Locally Advanced Cervical Cancer”, participants will be able to: Discuss how combinations of immune checkpoint inhibitors plus chemoradiotherapy regimens may address unmet needs in patients with locally advanced cervical cancer (LACC); Evaluate the clinical significance of the latest efficacy and safety data for the combination of immune checkpoint inhibitors and chemoradiotherapy regimens in LACC; and Integrate patient-centred, multidisciplinary management strategies to enhance the care of patients with LACC.

Listen